Dashboard
Manage Tickers

GNLX GENELUX Corp

Nasdaq www.genelux.com


$ 5.81 $ 0.36 (6.72 %)    

Friday, 17-Oct-2025 19:26:21 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 5.72
$ 5.42
$ 5.35 x 100
$ 6.01 x 200
$ 5.29 - $ 5.88
$ 1.99 - $ 5.89
221,652
na
216.06M
$ 0.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

genelux-q2-eps-020-beats-022-estimate
Genelux Q2 EPS $(0.20) Beats $(0.22) Estimate
08/07/2025 20:40:39

Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9....

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/21/2025 21:06:05

lucid-capital-markets-initiates-coverage-on-genelux-with-buy-rating-announces-price-target-of-10
LUCID CAPITAL MARKETS Initiates Coverage O...
07/21/2025 17:35:31

LUCID CAPITAL MARKETS analyst Christopher Liu initiates coverage on Genelux (NASDAQ:GNLX) with a Buy rating and announces Pr...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 17:06:16

benchmark-maintains-speculative-buy-on-genelux-lowers-price-target-to-23
Benchmark Maintains Speculative Buy on Gen...
05/08/2025 14:04:10

Benchmark analyst Bruce Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and lowers the price target from $25 ...

genelux-q1-eps-021-beats-024-estimate
Genelux Q1 EPS $(0.21) Beats $(0.24) Estimate
05/06/2025 20:40:25

hc-wainwright--co-reiterates-buy-on-genelux-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Gene...
03/31/2025 10:52:01

HC Wainwright & Co. analyst Emily Bodnar reiterates Genelux (NASDAQ:GNLX) with a Buy and maintains $30 price target.

genelux-q4-eps-095-up-from-116-yoy
Genelux Q4 EPS ($0.95) Up From ($1.16) YoY
03/28/2025 20:15:07

hc-wainwright--co-reiterates-buy-on-genelux-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Gene...
03/25/2025 15:42:00

HC Wainwright & Co. analyst Emily Bodnar reiterates Genelux (NASDAQ:GNLX) with a Buy and maintains $30 price target.

genelux-concluded-meeting-with-fda-for-oli-vec-in-treatment-of-prroc
Genelux Concluded Meeting With FDA For Oli...
03/25/2025 12:34:04

In response to a question seeking the FDA's guidance on their expectations regarding a confirmatory trial using the ongoing...

genelux-and-newsoara-announce-preliminary-phase-1b2-data-of-olvi-vec-in-advanced-small-cell-lung-cancer
Genelux And Newsoara Announce Preliminary ...
03/25/2025 12:32:51

  Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two...

genelux-prices-105m-underwritten-offering-of-3m-shares-at-350share
Genelux Prices $10.5M Underwritten Offerin...
03/25/2025 12:32:02

genelux-corp-tapped-matthew-pulisic-of-arrowhead-pharma-as-cfo-effective-january-30
Genelux Corp Tapped Matthew Pulisic Of Arr...
02/03/2025 11:49:21

Genelux Corporation (NASDAQ:GNLX), a late clinical-stage immuno-oncology company, today announced that Matthew Pulisic has join...

disney-to-rally-around-20-here-are-10-top-analyst-forecasts-for-friday
Disney To Rally Around 20%? Here Are 10 To...
11/15/2024 12:48:40

hc-wainwright--co-maintains-buy-on-genelux-lowers-price-target-to-30
HC Wainwright & Co. Maintains Buy on Genel...
11/15/2024 12:25:25

HC Wainwright & Co. analyst Emily Bodnar maintains Genelux (NASDAQ:GNLX) with a Buy and lowers the price target from $32...

genelux-q3-2024-gaap-eps-019-beats-020-estimate
Genelux Q3 2024 GAAP EPS $(0.19) Beats $(0...
11/14/2024 21:21:05

Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 ...

guggenheim-initiates-coverage-on-genelux-with-buy-rating-announces-price-target-of-8
Guggenheim Initiates Coverage On Genelux w...
10/29/2024 09:49:49

Guggenheim analyst Kelsey Goodwin initiates coverage on Genelux (NASDAQ:GNLX) with a Buy rating and announces Price Target o...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/22/2024 20:31:06

genelux-says-first-patient-dosed-in-us-based-phase-2-trial-evaluating-systemically-delivered-olvi-vec-in-patients-with-recurrent-non-small-cell-lung-cancer-interim-readout-expected-mid-2025
Genelux Says First Patient Dosed In US-Bas...
10/22/2024 20:10:25

VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician'...

why-gitlab-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket
Why GitLab Shares Are Trading Higher By Ar...
09/04/2024 10:39:51

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION